Elsoff, 19.03.2026 – According to preliminary figures, PLANOPTIK AG generated revenue of EUR 11,274 thousand in the 2025 financial year, compared with EUR 11,858 thousand in the previous year. These figures were slightly below the previous year’s level due to the poor economic conditions and inventory reduction at major customers.

In […]

Elsoff, 28.11.2025 – The PLANOPTIK Group is expected to close the 2025 financial year with sales revenues of between EUR 11 and 12 million, slightly below the previous year’s level. In fiscal year 2024, PLANOPTIK generated consolidated sales revenues of EUR 11.9 million.

The prolonged period of poor macroeconomic conditions has […]

Elsoff, 22.08.2025 – In the first half of 2025, the PLANOPTIK Group generated sales revenues at the previous year’s level and is expected to have achieved a slightly positive EBT. According to initial figures, EBT was thus slightly below the same period of the previous year.

The first half of 2025 […]

13.03.2025 – According to preliminary figures, the PLANOPTIK Group generated revenue of EUR 11,861 thousand in the 2024 financial year. In the 2023 financial year, revenue amounted to EUR 13,253 thousand.

The decline in the past financial year is primarily due to the fact that major customers and their customers reduced […]

Elsoff, 02.08.2024 – According to preliminary figures, PLANOPTIK AG’s consolidated sales in the first half of 2024 amounted to EUR 5,952 thousand (previous year: EUR 6,649 thousand). The decline in sales is due to what are likely to be temporary inventory adjustments at important customers. The newly acquired projects were […]

Elsoff, 22.07.2024 – PLANOPTIK AG (formerly Plan Optik AG) is seeking to change its stock market segment to the Regulated Market (General Standard). The shares of PLANOPTIK AG are currently listed on the Basic Board of the Open Market of the Frankfurt Stock Exchange.

Preparations for this are to begin in […]

According to preliminary figures, Plan Optik AG’s consolidated sales increased by EUR 1,787 thousand in the 2023 financial year from EUR 11,466 thousand to EUR 13,253 thousand. Consolidated sales had already increased by EUR 1,999 thousand in 2022. The strong growth in 2023 is largely due to successful medical and […]